These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28987596)

  • 1. Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury.
    Gao X; Fu T; Wang C; Ning C; Kong Y; Liu Z; Sun H; Ma X; Liu K; Meng Q
    Biochem Pharmacol; 2017 Dec; 146():127-138. PubMed ID: 28987596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
    Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor.
    Wang J; Fu T; Dong R; Wang C; Liu K; Sun H; Huo X; Ma X; Yang X; Meng Q
    Food Funct; 2019 Jul; 10(7):3839-3850. PubMed ID: 31210195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor.
    Gao X; Wang C; Ning C; Liu K; Wang X; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Food Funct; 2018 May; 9(5):2684-2694. PubMed ID: 29721568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
    Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
    Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
    Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
    Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.
    Carino A; Biagioli M; Marchianò S; Fiorucci C; Bordoni M; Roselli R; Di Giorgio C; Baldoni M; Ricci P; Monti MC; Morretta E; Zampella A; Distrutti E; Fiorucci S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158733. PubMed ID: 32371093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
    Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
    Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury.
    Lu Q; Zhu Y; Wang C; Zhang R; Miao Y; Chai Y; Jiang Z; Yu Q
    Life Sci; 2024 Jan; 337():122355. PubMed ID: 38104861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
    Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
    Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
    Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
    Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.
    Panzitt K; Jungwirth E; Krones E; Lee JM; Pollheimer M; Thallinger GG; Kolb-Lenz D; Xiao R; Thorell A; Trauner M; Fickert P; Marschall HU; Moore DD; Wagner M
    J Hepatol; 2020 Jun; 72(6):1122-1131. PubMed ID: 32001325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
    Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
    J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
    Yang F; Wang Y; Li G; Xue J; Chen ZL; Jin F; Luo L; Zhou X; Ma Q; Cai X; Li HR; Zhao L
    Br J Pharmacol; 2018 Mar; 175(5):810-829. PubMed ID: 29235094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
    Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
    Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.